Detailed information for compound 73992

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 507.532 | Formula: C28H29NO8
  • H donors: 1 H acceptors: 2 LogP: 2.1 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCOc1ccc2c(c1)[C@H](c1cc(OC)c(c(c1)OC)OC)N([C@@H]2c1ccc2c(c1)OCO2)CC(=O)O
  • InChi: 1S/C28H29NO8/c1-5-35-18-7-8-19-20(13-18)27(17-11-23(32-2)28(34-4)24(12-17)33-3)29(14-25(30)31)26(19)16-6-9-21-22(10-16)37-15-36-21/h6-13,26-27H,5,14-15H2,1-4H3,(H,30,31)/t26-,27+/m1/s1
  • InChiKey: JBMMQCZBDFDLEC-SXOMAYOGSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens endothelin receptor type B Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi NADH-ubiquinone oxidoreductase, mitochondrial, putative 0.0273 1 0.5
Leishmania major NADH-ubiquinone oxidoreductase, mitochondrial, putative 0.0273 1 0.5
Onchocerca volvulus NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial homolog 0.0146 0 0.5
Echinococcus granulosus NADH dehydrogenase ubiquinone flavoprotein 1 0.0273 1 0.5
Trichomonas vaginalis NADH-ubiquinone oxidoreductase flavoprotein, putative 0.0273 1 0.5
Trypanosoma brucei NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, putative 0.0273 1 0.5
Trypanosoma cruzi NADH-ubiquinone oxidoreductase, mitochondrial, putative 0.0273 1 0.5
Mycobacterium ulcerans NADH dehydrogenase I subunit F 0.0273 1 0.5
Schistosoma mansoni NADH-ubiquinone oxidoreductase 0.0273 1 0.5
Trichomonas vaginalis NADH-ubiquinone oxidoreductase flavoprotein, putative 0.0273 1 0.5
Wolbachia endosymbiont of Brugia malayi NADH dehydrogenase I subunit F 0.0273 1 0.5
Loa Loa (eye worm) NADH-ubiquinone oxidoreductase 51 kDa subunit 0.0273 1 0.5
Trypanosoma brucei NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial 0.0273 1 0.5
Mycobacterium tuberculosis Probable NADH dehydrogenase I (chain F) NuoF (NADH-ubiquinone oxidoreductase chain F) 0.0273 1 0.5
Echinococcus multilocularis NADH dehydrogenase (ubiquinone) flavoprotein 1 0.0273 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 1100 nM In vitro inhibition of [125I]-ET-1 binding to CHO cells expressing recombinant human Endothelin A receptor ChEMBL. 11425549
IC50 (binding) = 1100 nM In vitro inhibition of [125I]-ET-1 binding to CHO cells expressing recombinant human Endothelin A receptor ChEMBL. 11425549
Inhibition (binding) = 15 % Inhibition of [125I]-ET-1 binding to CHO cells expressing human Endothelin B receptor at a concentration of 1 uM ChEMBL. 11425549
Inhibition (binding) = 15 % Inhibition of [125I]-ET-1 binding to CHO cells expressing human Endothelin B receptor at a concentration of 1 uM ChEMBL. 11425549

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.